Chromatin condensation and nuclear fragmentation, typical markers of apoptosis, were dose-dependently increased by ESB treatment in EGFR TKI-resistant human NSCLC cell lines (Figure 5A). This evidence concerns the gene EGFR and non-small cell lung carcinoma.